Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business

SNY or LLY: Which Is the Better Value Stock Right Now?

04:40pm, Friday, 30'th Dec 2022 Zacks Investment Research
SNY vs. LLY: Which Stock Is the Better Value Option?
SNY vs. LLY: Which Stock Is the Better Value Option?
Finding the right cheap large-cap stocks to buy can be a challenge. As we enter 2023, the macro issues that have defined the last year continue to persist: inflation remains high, interest rates keep

Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More

04:36pm, Thursday, 29'th Dec 2022 Zacks Investment Research
Updates from Gilead Sciences (GILD) and ProQR (PRQR) are the key highlights from the biotech sector during the past week.
Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's

Eli Lilly (LLY) Gains As Market Dips: What You Should Know

10:45pm, Wednesday, 28'th Dec 2022 Zacks Investment Research
In the latest trading session, Eli Lilly (LLY) closed at $365.22, marking a +0.09% move from the previous day.

2023 Market Outlook: 15 Top Stock Picks for the New Year

04:11pm, Wednesday, 28'th Dec 2022 Investing.com
Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs. The post The Battles Brewing That Could Stoke Already Red-H

Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know

10:50pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
In the latest trading session, Eli Lilly (LLY) closed at $364.88, marking a -0.82% move from the previous day.
These dividend stocks should easily withstand a recession.

ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly

05:14pm, Friday, 23'rd Dec 2022 Zacks Investment Research
ProQR (PRQR) expands its existing licensing and collaboration agreement with Eli Lilly for the discovery, development and commercialization of new genetic medicines.

MGV: Mega Cap Value ETF, Wrap It Up And Put A Bow On Top

05:23am, Friday, 23'rd Dec 2022 Seeking Alpha
The Vanguard Mega Cap Value ETF has outperformed the S&P 500 by ~16% over the past year. Read why I feel MGV ETF is very attractive.
United Therapeutics, Intra-Cellular Therapies, Immunocore Holdings and Eli Lilly are part of the Zacks top Analyst Blog.
For investors not cowed by this year and ready to look ahead at where some gains may come from, we've got a couple ideas from the son of a legendary investor.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE